Most Targeted Cancer Drugs Lack Substantial Clinical BenefitApril 17, 2024Breast CancerGenitourinary CancerLung CancerMelanomaMixed TopicsBusiness of MedicineAML
EBER-Negative, Double-Hit High-Grade B-Cell Lymphoma Responding to Methotrexate DiscontinuationApril 8, 2024OncologyProstate Cancer
Study Shows Nirmatrelvir–Ritonavir No More Effective Than Placebo for COVID-19 Symptom ReliefApril 5, 2024COVID-19 UpdatesPulmonologyInfectious Diseases
Evaluation of Anti-Agitation Medication Prescribing Patterns by Age in the Emergency DepartmentApril 1, 2024Mental Health
No Increased Stroke Risk After COVID-19 Bivalent VaccineMarch 28, 2024StrokePulmonologyCardiologyCOVID-19 Updates
